Proactive diarrhea management improved tolerability of pyrotinib in combination with trastuzumab and docetaxel in patients with HER2+early or locally advanced breast cancer: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study
CANCER RESEARCH(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined